Skip to main content

Advertisement

Table 3 Cox regression of predictors of mortality in lupus patients from the RELESSER-TRANS cohort

From: Primary respiratory disease in patients with systemic lupus erythematosus: data from the Spanish rheumatology society lupus registry (RELESSER) cohort

  Hazard ratio 95% confidence interval P value
Pleuropulmonary manifestations 3.13 1.56–6.28 0.001
Age 0.99 0.96–1.01 0.293
Gender 0.89 0.31–2.52 0.825
Infections 0.79 0.39–1.59 0.506
Nephritis 0.74 0.23–2.39 0.612
Cardiac disease 1.01 0.42–2.42 0.978
Cardiovascular events 1.57 0.32–7.66 0.577
SLEDAI score 1.08 1.00–1.16 0.052
SLICC score 1.79 0.69–0.92 0.002
  1. Abbreviations: RELESSER-TRANS Registry of Systemic Lupus Erythematosus Patients of the Spanish Society of Rheumatology [SER], cross-sectional phase, SLEDAI Systemic Lupus Erythematosus Disease Activity Index, SLICC Systemic Lupus International Collaborating Clinics